Antimicrobial activity of ceftazidime-avibactam and comparators against levofloxacin-resistant Escherichia coli collected from four geographic regions, 2012–2018

BACKGROUND: Increases in resistance to fluoroquinolones have been correlated with the use of levofloxacin in the treatment of infections caused by Escherichia coli. The analysis presents the in vitro activity of ceftazidime-avibactam and comparator agents against 10,840 levofloxacin-resistant E. col...

Descripción completa

Detalles Bibliográficos
Autores principales: Stone, Gregory G., Hackel, Meredith A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939136/
https://www.ncbi.nlm.nih.gov/pubmed/35313912
http://dx.doi.org/10.1186/s12941-022-00504-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939136/
https://www.ncbi.nlm.nih.gov/pubmed/35313912
http://dx.doi.org/10.1186/s12941-022-00504-8

Ejemplares similares